Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Exelixis Inc. (EXEL)

15.93 -0.74 (-4.44%)

11-12 16:00

Open:

16.57

Pre. Close:

16.67

High:

16.77

Low:

15.6994

Volume:

4,449,021

Market Cap:

4763M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

16.788 - 16.925

16.925 - 17.017

Low:

15.428 - 15.573

15.573 - 15.67

Close:

15.739 - 15.965

15.965 - 16.116

Technical analysis  (as of: 2018-11-12 4:24:39 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 19.85     One year: 22.43

Support:

Support1: 13.42    Support2: 11.17

Resistance:

Resistance1: 16.99    Resistance2: 19.20

Pivot:

15.58

Moving Averages:

MA(5): 16.80     MA(20): 15.79

MA(100): 18.57     MA(250): 22.34

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.25

%K %D:

%K(14,3): 54.56     %D(3): 60.42

RSI:

RSI(14): 47.75

52-Week:

High: 32.2  Low: 13.42  Change(%): -36.6

Average Vol(K):

3-Month: 388841  10-Days 544380

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
EXEL has closed below upper band by 43.9%. Bollinger Bands are 91.5% wider than normal. The large width of the bands suggest high volatility as compared to EXEL's normal range. The bands have been in this wide range for 13 bars. This is a sign that the current trend might continue.

Headline News

2018-11-07T08:00:00-05:00
Cancer Research Highlight: AVEO Oncology Hatches Its Big Breakout In Kidney Cancer

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

298.98

Shares Float (M)

293.97

% Held by Insiders

1.70

% Held by Institutions

68.20

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

1.180

EPS Est. Current Year

0.280

EPS Est. Next Year

0.670

EPS Est. Next Quarter

0.090

Forward EPS

1.280

Book Value (p.s.)

5.590

PEG Ratio

0.29

Profit Margin

49.53

Operating Margin

47.85

Return on Assets (ttm)

45.1

Return on Equity (ttm)

63.8

Qtrly Rev. Growth

88.0

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

395.50

Operating Cash Flow (M)

237.80

Levered Free Cash Flow (M)

71.57

Valuation

P/E

13.50

P/E Growth Ratio

-0.04

P/BV

2.85

P/S

2098128384.00

P/CF

20.03

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.